Jersey City, NJ, United States of America

Vaibhav Maheshwari

This inventor holds 7 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 2 EPO patents. Top assignees: Fresenius Medical Care Holdings, Inc., Fresenius Medical Care Deutschland Gmbh. Active years: 2021-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Vaibhav Maheshwari. Retrieved from https://idiyas.com/inventor/vaibhav-maheshwari

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2021-2026

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Vaibhav Maheshwari: Innovator in Dialysis Technology

Introduction

Vaibhav Maheshwari is a prominent inventor based in Jersey City, NJ (US). He has made significant contributions to the field of dialysis technology, holding a total of 7 patents. His work focuses on improving dialysis processes and enhancing patient care through innovative techniques.

Latest Patents

Maheshwari's latest patents include groundbreaking techniques for removing bound target substances during dialysis. These systems, methods, and apparatuses are designed to perform a dialysis process that incorporates a displacer infusion process. The dialysis machine he has developed includes at least one processor and a memory that contains instructions for accessing dialysis information. This information indicates a target substance to be displaced from a binding compound by a displacer, allowing for a tailored infusion profile during the dialysis process.

Another notable patent involves techniques for modeling and optimizing dialysis toxin displacer compounds. This method includes constructing a variety of target protein quantitative structure-activity relationship (QSAR) models for different binding sites. By analyzing candidate compounds using these models, Maheshwari can identify potential displacer compounds with the desired affinity for binding, thereby enhancing the efficacy of dialysis treatments.

Career Highlights

Vaibhav Maheshwari is currently employed at Fresenius Medical Care Holdings, Inc., where he continues to innovate in the field of dialysis technology. His work has been instrumental in advancing the capabilities of dialysis machines and improving patient outcomes.

Collaborations

Maheshwari collaborates with esteemed colleagues such as Peter Kotanko and Stephan Thijssen. Their combined expertise contributes to the development of cutting-edge solutions in dialysis treatment.

Conclusion

Vaibhav Maheshwari's contributions to dialysis technology exemplify the impact of innovation in healthcare. His patents and collaborative efforts are paving the way for more effective and efficient dialysis processes, ultimately benefiting patients worldwide.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…